Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
One perk to marrying Richard Marx later in life? 'We don't have time' for stupid arguments, says Daisy Fuentes. - 2Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- 3No more attempts to free whale stranded off Germany, officials say
- 4Banks for High Fixed Store Rates: Augment Your Investment funds
- 5Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- The Conclusive Manual for Spending plan Travel: Opening Undertakings on a Tight budget
- How federal officials talk about health is shifting in troubling ways – and that change makes me worried for my autistic child
- The Best Internet based Courses for Expertise Improvement
- 25 Most Beautiful Villages in France You Can Actually Visit
- New subclade K flu strain raises concerns: What families should know
- How AI fixed the James Webb Space Telescope's blurry vision
- Party Urban areas of the World
- Israeli president concerned over proposed renaming of park
- 'Euphoria' releases Season 3 photos with Zendaya, Sydney Sweeney, Jacob Elordi and others: See them
